Chronic kidney disease (CKD)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Eligibility criteria include the following: 15 years of age or older; hospitalized in Nagoya City University hospital; diagnosed as having chronic kidney disease (CKD) based on K/DOQI criteria (either kidney damage or glomerular filtration of <60 mL/min/1.73m2 for 3 months or more); and written informed consent was obtained.
Exclusion criteria
Exclusion criteria: Exclusion criteria are as follows; use of inhibitors of renin-angiotensin system or diuretics 1 month before enrollment; specific contraindication to a study drug; HbA1c of 9.0 % or above; serious liver damage (GOT >100, or GPT >85); secondary hypertension; accelerated or malignant hypertension (progressive renal dysfunction with diastolic BP of >120-130 mmHg); serious congestive heart failure, coronary heart disease, arrhythmia, or systemic diseases; presence or possibility of pregnancy; or any reason for ineligibility suggested by the attending doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration in days since diuretics alone, or in combination with ARB, are administered until nocturnal BP becomes lower than 90% of daytime averages. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the night/day ratio of urinary albumin excretion, 24-h BP, glomerular filtration rate, daily urinary albumin excretion, HbA1c, and serum uric acid, or any adverse event | — |
Countries
Japan
Contacts
Nagoya City University Graduate School of Medical Sciences Department of Cardio-Renal Medicine and Hypertension